Senhwa Biosciences, Inc. (6492.TWO)
TWD 31.65
(-4.81%)
TWD 31.65
(-4.81%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -311.11 Million TWD | 12.64% |
| 2022 | -356.11 Million TWD | -2.83% |
| 2021 | -346.31 Million TWD | 3.6% |
| 2020 | -359.25 Million TWD | 8.77% |
| 2019 | -393.8 Million TWD | -1.63% |
| 2018 | -387.46 Million TWD | -3.22% |
| 2017 | -375.39 Million TWD | -45.49% |
| 2016 | -258.01 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -73.5 Million TWD | -10.2% |
| 2024 Q1 | -66.7 Million TWD | 22.95% |
| 2023 Q3 | -78.92 Million TWD | -15.02% |
| 2023 Q1 | -77 Million TWD | 18.03% |
| 2023 Q2 | -68.61 Million TWD | 10.89% |
| 2023 Q4 | -86.57 Million TWD | -9.7% |
| 2023 FY | -311.11 Million TWD | 12.64% |
| 2022 Q2 | -98.97 Million TWD | -25.93% |
| 2022 FY | -356.11 Million TWD | -2.83% |
| 2022 Q4 | -93.93 Million TWD | -11.03% |
| 2022 Q3 | -84.6 Million TWD | 14.52% |
| 2022 Q1 | -78.59 Million TWD | 5.48% |
| 2021 FY | -346.31 Million TWD | 3.6% |
| 2021 Q4 | -83.15 Million TWD | 7.01% |
| 2021 Q3 | -89.42 Million TWD | 0.0% |
| 2020 FY | -359.25 Million TWD | 8.77% |
| 2019 FY | -393.8 Million TWD | -1.63% |
| 2018 FY | -387.46 Million TWD | -3.22% |
| 2017 FY | -375.39 Million TWD | -45.49% |
| 2016 FY | -258.01 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 210.381% |
| Level Biotechnology Inc. | 67.55 Million TWD | 560.55% |
| TaiMed Biologics Inc. | -166.23 Million TWD | -87.156% |
| GlycoNex Incorporation | -259.86 Million TWD | -19.721% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | -35.687% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 85.113% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -13708.744% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | -266.039% |
| Visgeneer Inc. | -21.15 Million TWD | -1370.348% |
| Neith Corporation | -48.85 Million TWD | -536.818% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 17.175% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 74.369% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -4606.672% |
| Enimmune corporation | -243.47 Million TWD | -27.779% |
| TaiRx, Inc. | -214.69 Million TWD | -44.908% |
| CHO Pharma, Inc. | -268.99 Million TWD | -15.656% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 591.215% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | -331.523% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 192.118% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 1387.605% |
| Lukas Biomedical Inc. | -43.56 Million TWD | -614.213% |
| RBC Bioscience Corporation | 14.53 Million TWD | 2239.838% |
| NaviFUS Corp. | -76.42 Million TWD | -307.075% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 55.179% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | -396.324% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | -372.669% |
| Sagittarius Life Science Corp | -64.37 Million TWD | -383.272% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | -340.78% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | -233.324% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | -76.226% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 485.592% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | -359.564% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 71.635% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | -448.223% |
| AP Biosciences Inc | -347.47 Million TWD | 10.466% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 134.769% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 193.124% |
| EirGenix Inc. | -1.03 Billion TWD | 69.853% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | -10916.678% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 48.329% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -583.73% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -649.99% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | -266.254% |
| VBI | -16.13 Million TWD | -1828.533% |
| BiOptic Inc. | 44.05 Million TWD | 806.22% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | -231.128% |
| Sinew Pharma Inc. | -186.25 Million TWD | -67.037% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 294.667% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 74.77% |
| 3D Global Biotech Inc. | -62.85 Million TWD | -394.982% |
| Intech Biopharm Corporation | -304.39 Million TWD | -2.206% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 71.63% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | -83.486% |
| TCI GENE Inc. | 10.04 Million TWD | 3195.94% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | -144.475% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | -46.609% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 9159.726% |
| PharmaEngine, Inc. | 277.18 Million TWD | 212.24% |
| Savior Lifetec Corporation | -2.42 Million TWD | -12755.826% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | -78.084% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | -152.619% |
| Acepodia, Inc. | -435.97 Million TWD | 28.64% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 36.242% |